A strategy of combining IV cangrelor (Kengreal; Chiesi) and crushed ticagrelor in STEMI patients undergoing primary PCI—to cover the delay in absorption of the oral drug—enhances platelet inhibition ...
Background: Dual antiplatelet therapy is the standard of care for acute coronary syndrome, but uncertainty exists regarding the optimal regimen for patients in North America. We sought to compare the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback